Диссертация (1139978), страница 33
Текст из файла (страница 33)
Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and withdementia / Ibarretxe-Bilbao N., Ramírez-RuizB., Tolosa E., Martí M.J., Valldeoriola F., Bargalló N, et al.//J Neurol . – 2008–vol. 255–p. 1324-31.109. Inzelberg R. Association between amantadine and the onset of dementia in Parkinson’s disease. / Inzelberg R., Bonuccelli U., Schechtman E., Miniowich A.,Strugatsky R., Ceravolo R.et al.// Mov Disord – 2006 – Vol.21 – р.1375–1379.110.
Janvin C.C.Subtypes of mild cognitive impairment in Parkinson’s dis.ease: progression todementia / Janvin C.C., Larsen J.P., Aarsland D., Hugdahl K.// MovDisord–2006–Vol.21–р.1343–1349.111. Janvin C.C. Cognitive profiles of individual patients with Parkinson's disease anddementia: comparison with dementia with Lewy bodies and Alzheimer's disease /Janvin C.C., Larsen J.P., Salmon D.P., Galasko D., Hugdahl K., Aarsland D. //Mov Disord. –2006.
–Vol.21–р. 337–342.112. Janzen J. The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-basedmorphometry study / JanzenJ., van’t Ent D., Lemstra A.W., Berendse H.W., Barkhof F., Foncke E.M.J.// JNeurol .–2012.–Vol. 259.–р.147-54.113. Johnson D. K.
Longitudinal Changes in Cognition in Parkinson’s Disease withand without Dementia / D. K. Johnson, James E. Galvin B.//Dement Geriatr CognDisord– 2011–Vol.31–р. 98–108.114. Jones B.E. Activity, modulation and role of basal forebrain cholinergic neuronsinnervating thecerebral cortex / Jones B.E. // Prog Brain Res. – 2004.
–Vol. 145.–р. 157-69.115. Junqué C.Amygdalar andhippocampal MRI volumetric reductions in Parkinson’sdisease with dementia / Junqué C., Ramírez-Ruiz B., Tolosa E., Summerfield C.,Martí M-J, Pastor P., et al. . //MovDisord.–2005.–Vol. 20.–p. 540-4.189116. Kalaitzakis M.E.Dementia andvisual hallucinations associated with limbic pathology in Parkinson’s disease / Kalaitzakis M.E., Christian L.M., Moran L.B.,Graeber M.B., Pearce R.K.B., Gentleman SM.// Parkinsonism RelatDisord –2009 –Vol. 15 – p. 196-204.117.
Kalmbach A. Selective optogenetic stimulation of cholinergic axons inneocortex /Kalmbach A., Hedrick T., Waters J. //J Neurophysiol. – 2012.– Vol. 107.–p.2008-19.118. Kastner S. Mechanisms of visual attention in the human cortex / Kastner S., Ungerleider L.G. // Annu RevNeurosci.–2000.–Vol. 23–р.315-41.119. Kehagia A.A. Cognitive impairment in Parkinson’s Disease: the dual syndromehypothesis / Kehagia A.A.,Barker R.A. // Neurodegener.Dis – 2013.–Vol.11.–р.79-92.120. Kim Y. Cognitive and Neuroanatomical Correlates in Early Versus Late OnsetParkinson's Disease Dementia.
Journal Of Alzheimer's Disease /Kim Y., Lee D.,Cho K.H.// JAD [J Alzheimers Dis] – 2016 – Nov 19 – Vol. 55 (2) – p. 485-495121. Klein J.C. Neurotransmitter changes in dementia with Lewy bodies and Parkinsondisease dementia in vivo / Klein J.C., Eggers C., Kalbe E., et al. // Neurology.–2010–Vol.74 –p. 885–92.122.
Kormack F. Pentagon drawing and neuropsychological performance in Dementiawith Lewy bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia / Kormack F., Aarsland D., Ballard C., Tovee M.J. //Int J Geriatr Psychiatry.–2004–Vol.19–p. 371–377,123. Korczyn A.D. Vascular Contribution to Dementia in Parkinson’s Disease/Korczyn A.D. // Neurodegenerative Dis–2010–Vol.7–p. 127–130124. Kulisevsky J., Cognitive impairment in Parkinson’s disease Tools for diagnosisand assessment /Kulisevsky J., Pagonabarraga J. // Mov.Disord.
– 2009. – Vol.24.– р.1103-1110.125. Kurlan R.Quetiapin for agitationor psychosis inpatients with dementia and parkinsonism /Kurlan R.,Cumming J.,Raman R.at al. // Neurology. – 2007. –Vol.68–p. 1356-1363.190126. Kuzis G. Explicit and implicit learning in patients with Alzheimer disease andParkinson disease with dementia / Kuzis G., Sabe L., Tiberti C., Merello M.,Leiguarda R, Starkstein S.E. // Neuropsychiatry Neuropsychol Behav Neurol.–1999.–Vol.12–р.265–269.127.
Lee D.G. The cross-sectional and longitudinal relationships between white matterhyperintensities and dementia in patients with Parkinson's disease: A retrospective analysis of 132 patients in a single center Archives Of Gerontology and Geriatrics /D. G. Lee //Arch Gerontol Geriatr.–2016–Jan-Feb.–Vol. 62–р. 133-7.128. Lee S.H. Brain volumetry in Parkinson’s disease with and without dementia:where are the differences? / Seung-Hwan Leе, Sam Soo Kim, Woo-Suk Tae at al.// Acta Radiol.
–2013. – Vol. 54. –p. 581 -7.129. Lee S.Y. Dementia-Free Survival and Risk Factors for Dementia in a HospitalBased Korean Parkinson's Disease Cohor /Lee S.Y., Ryu H.J., Seo J.W. //JournalOf Clinical Neurology (Seoul, Korea) [J Clin Neurol].–2016 –Oct –Vol.7–р. 1876130. Lech R.K.The medial temporal lobe: memory and beyond / Lech R.K., Suchan B.// Behav Brain Res. – 2013.– Vol.. 254–p. 45-9131. Levy G.Combined effect of age and severity on the risk of dementia inParkinson’s disease /Levy G., Schupf N., Tang M.X., Cote L.J., Louis E.D., Mejia H.etal //Ann Neurol. – 2002. – Vol.51 – р.722–729132.
Lin C.H. Plasma a-synuclein predicts cognitive decline in Parkinson s disease /Lin C.H // J. Neurosurg. Psychiatry. – 2016. – Pii: jnnp 2016-314857.doi10/1136.jnnp – 2016-314857.133. Litvan I. Differential memory and executive functions in demented patients withParkinson's and Alzheimer's disease / Litvan I., Mohr E., Williams J., Gomez C.,Chase T.N. // J Neurol Neurosurg Psychiatry. – 1991.–Vol.54 – р.
25–29.134. Lezak M. D. Neuropsychology assessment /M. D. Lezak – NY: University Press.– 1983.– р.768.191135. Luk K.C. Exogenous alpha-synuclein fibrils seed the formationofLewy body –like intracellular inclusion incultured cells / Luk K.C., Song C.,O Brien P. etal.//PNAS.- 2009 – Vol.106 – р.
20051-20056.136. Marder K. The frequency and associated risk factors for dementia in patients withParkinson's disease / Marder K., Tang M.X., Cote L., Stern Y., Mayeux R. // ArchNeurol. – 1995.– Vol.52 – р. 695 – 701.137. Marder K. Postmenopausal estrogen use and Parkinson’s disease with and without dementia / Marder K., Tang M.X., Alfaro B., Mejia H., Cote L., Jacobs D.,Stern Y., Sano M., Mayeux R.//Neurology. – 1998.– Vol.50 – р.1141– 1143.138. Marié R.M. Relationships between striatal dopaminedenervation and frontal executive tests in Parkinson’s disease / Marié R.M., Barré L., Dupuy B., Viader F.,Defer G., Baron J.C.
// Neurosci Lett . – 1999. – Vol. 260.– p. 77-80.139.Docherty M. J. Parkinson’s Disease Dementia / Mary J. Docherty, David J. Burn//Curr Neurol Neurosci Rep.–2010.–р. 292–298.140. MattisS. Mental status examination for organic mental syndrome in theeldery patients /Mattis S. //Ger Psychiatr.. – NY.: Grune, Stratton.–1976.141. McLin D.E. Induction of behavioral associative memory bystimulation of thenucleus basalis / McLin D.E., Miasnikov A.A., Weinberger N.M. // Proc NatlAcad Sci USA. – 2002. –Vol. 99.–p.
4002-7.142. Menon V.Saliency, switching, attention and control: a network model of insulafunction / Menon V., Uddin L.Q. //Brain Struct Funct.–2010. –Vol. 214.–p. 65567.143. Melzer T.R. Grey matter atrophyin cognitively impaired Parkinson’s disease /Melzer T.R., Watts R., MacAskill M.R., Pitcher T.L., Livingston L., Keenan R.J.,et al. //J Neurol Neurosurg Psychiatry. – 2012.–Vol. 83.–p.
188-94.144. Meppelink A.M.Impaired visualprocessing preceding image recognition in Parkinson’s disease patients with visual hallucinations / Meppelink A.M., de JongB.M., Renken R., Leenders K.L., Cornelissen F.W., van Laar T. // Brain. – 2009.–vol. 132.–p. 2980-93.192145. Middleton F.A. Basal ganglia and cerebellar loops: motor and cognitive circuits /Middleton F.A., Strick P.L. //Brain Res Rev . – 2000. –Vol. 31–p. 236-50.146.
Minett T.S.C. What happens when donepezil is suddenly withdrawn? An openlabel trial in dementia with Lewy bodies and Parkinson’s disease with dementia /Minett T.S.C., Thomas A., Wilkinson L.M., et al. // Int J Geriatr Psychiatry. –2003.–18–р.988-993.147. Molloy S.A. Effect of levodopa on cognitive function in Parkinson’s disease withand without dementia and dementia with Lewy bodies / Molloy S.A., RowanE.N., O’Brien J.T., McKeith I.G., Wesnes K., Burn D.J. // J Neurol NeurosurgPsychiatry. – 2006.–Vol.77.
– p.1323-1328.148. MorrisJ. С. The clinical dementia rating (CDR) currentversion and scoring rules /MorrisJ. С. // Neurology. –1993. – Vol 43. – p. 2412-2414149. Mosimann U.P. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies / Mosimann U.P., Rowan E.N., PartingtonC.E., et al. //Am J Geriatr Psychiatry. – 2006. – Vol.14. –p. 153–160.150. Noe E. Comparison of dementia with Lewy bodies to Alzheimer's disease andParkinson's disease with dementia / Noe E., Marder K., Bell K.L., Jacobs D.M.,Manly J.J., Stern Y. // Mov Disord. – 2004. – Vol.19.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
